{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a start-up exclusive license to VuEssence, which is located in Florida, to practice the inventions embodied in the following patents:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2015/10/02/2015-24988.html","cfr_references":[],"citation":"80 FR 59794","comment_url":null,"comments_close_on":"2015-10-19","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before October 19, 2015 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2015-24988","effective_on":null,"end_page":59794,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2015/10/02/2015-24988.xml","html_url":"https://www.federalregister.gov/documents/2015/10/02/2015-24988/prospective-grant-of-start-up-exclusive-license-differential-expression-of-molecules-associated-with","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2015-24988?publication_date=2015-10-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2015-10-02/2015-24988/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":66,"last_updated":"2026-07-28 06:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2015-10-02/pdf/2015-24988.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2015-24988.pdf?1443703564","publication_date":"2015-10-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2015/10/02/2015-24988.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T04:56:20Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":59794,"subtype":null,"title":"Prospective Grant of Start-Up Exclusive License: Differential Expression of Molecules Associated With Acute Stroke","toc_doc":"Differential Expression of Molecules Associated with Acute Stroke","toc_subject":"Exclusive Licenses:","topics":[],"type":"Notice","volume":80}